Avastin for brain swelling after radiation
Treatments studied
Part of Brain & nervous system, Cancer clinical trials.
This trial tests a drug called Avastin (bevacizumab) for people with brain swelling (radionecrosis) after radiation. It's for those whose symptoms don't get better with steroids or come back when steroids are reduced.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have brain swelling (radionecrosis) after radiation, and symptoms like headache or weakness persist or get worse despite steroids.
- You had radiation to your brain for metastases at least 3 months ago.
- You have never received Avastin (bevacizumab) for this brain swelling.
- Your overall health is reasonably good (able to care for yourself most of the day).
- Your kidney, liver, and blood counts are within a safe range for the study drug.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests combining a drug called bevacizumab with a focused radiation treatment for people with lung cancer that has spread to the brain. It compares this to the standard radiation approach, and aims to see which better preserves memory and controls tumors.
This trial tests if bevacizumab works better than steroids for people with brain swelling caused by radiation. If you have this condition and meet certain health requirements, you may join.
This trial tests whether using special MRI information to plan proton radiation, plus a drug called Avastin (bevacizumab), can help control recurrent glioblastoma (a fast-growing brain tumor) and improve outcomes. It mainly aims to treat tumor that has come back after prior standard radiation, using careful timing and imaging to target it safely.
This trial tests a combination of two drugs (SHR-A1921 and Avastin) to see if it can shrink or slow brain tumors caused by triple-negative breast cancer. It’s for people whose breast cancer has spread to the brain and haven’t had radiation to the brain yet.
This trial tests giving focused radiation (FSRT) along with Avastin (bevacizumab) to people with multiple brain metastases from lung adenocarcinoma. It aims to see if combining these treatments is safe and effective for tumors that are too large or numerous for standard one-time radiation.
This trial tests a combination of a drug that stops blood vessel growth (bevacizumab), immunotherapy, and focused radiation to treat melanoma that has spread to the brain and is causing symptoms. The goal is to see if this approach shrinks tumors and improves outcomes.
Hear when a new Radionecrosis of Brain trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.